Status:
COMPLETED
Time Restricted Eating Outcomes in Multiple Sclerosis
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Multiple Sclerosis
Diet, Healthy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this pilot study is to determine the preliminary efficacy, safety, and acceptability of time restricted feeding (TRF) among a sample of 12 adults with Relapsing-Remitting Multiple Scler...
Detailed Description
Multiple sclerosis (MS) is a chronic autoimmune disease characterized by demyelination and loss of axons in the central nervous system. Over the last decade there has been an influx of evidence demons...
Eligibility Criteria
Inclusion
- Diagnosed with Relapsing Remitting MS (RRMS)
- BMI between 18-50 kg.m2
- If on disease-modifying medications, stable for 6 months
- If not on disease-modifying medication, no medication usage within previous 6 months
- Able to walk 25 ft. with or without assistance
Exclusion
- Relapse within previous 30 days
- Actively engaged in a weight loss program or unwilling to follow assigned dietary timing pattern
- Regularly fasts \>15 hours/day
- Pregnant or breastfeeding
- Current use of insulin or sulfonylurea agents
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04389970
Start Date
October 1 2020
End Date
July 30 2021
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294